ACCME Call for Comment 2009: PhRMA Response
Recently, the Pharmaceutical Research and Manufacturers of America (PhRMA) issued their response to the ACCME Call for…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
ACCME 2009 Call for Comment: Alliance’s Response
In another solid effort to confront the necessary and important role industry places in continuing medical education (CME), The…
AMA CEJA 2009: Problems with Construction
Adding to the growing crowd of criticism against new proposals from Accreditation Council for Continuing Medical Education…
Institute of Medicine: Macy and IOM Conflicting Interests
In today’s National Review Online is a feature article “Conflicting Interests” outlining the close agenda that the Macy…
Massachusetts Pharmaceutical and Medical Device Manufacture Code of…
In one month a tsunami is going to be hitting the healthcare manufacturing sector and healthcare providers in the state of…
FDA: Pharmaceutical Cheerios?
I did not realize there were negative side effects or addiction problems with Cheerios but apparently the FDA thinks Cheerios are…
FDA: Presenting Risk Information in Prescription Drug and Medical Device…
This week, the U.S Food and Drug Administration (FDA) issued a draft Guidance for Industry titled "Presenting Risk Information…
FDA: Presenting Risk Information in Prescription Drug and Medical Device…
The Coalition for Healthcare Communication will be filing extensive comments on the FDA draft Guidance and solicits your…
APA: Proposes Guidelines for Members
This past week at the APA Annual Meeting, they held a session proposing new ethical guidelines for their association and members.…
Health Care Reform: Orszag Back on the Trial
In today’s Bloomberg is an article on Peter Orszag Director of the Office of Management and Budget (OMB) and his passion for…